2025 CDMO pricing data for 105 clinical and commercial mammalian biologics development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 77 biologics CDMOs specializing in mammalian cell culture
Technical focus on emerging antibody formats, with an in-depth look at the growing pace of bispecific antibody clinical trials
Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mammalian biologics trials, sourced from the FDA Clinical Trials Database
Immediate access to Nice Insight's Mammalian Biologics Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Access to Nice Insight's Mammalian Biologics Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming mammalian biologics trials.
Access to Nice Insight's Mammalian Biologics CDMO Pricing Data from 2019-2025, including regional price breakdowns for over 100 distinct outsourcing RFP service line items.
Access to Nice Insight's Mammalian Biologics CDMO Directory, including capabilities for more than 75 biologics outsourcing organizations across North America, Europe, and Asia.
Competitive Benchmkaring
75+ Mammalian CDMO Profiles
Clinical Trials Analysis
Biotech Funding Trends
Market Growth Projections
Manufacturing Challenges & Innovations
Over 1,000 hours of data collection and analysis —
including interviews with CDMO owners, PhDs and customers.